Skip to main content

Table 5 Comparisons of IC 50 s of uracil-derived compounds in their inhibitory effects on recombinant PfUDG activity, P. falciparum growth and cytotoxicity to HepG2 cell lines

From: Molecular characterization of Plasmodium falciparum uracil-DNA glycosylase and its potential as a new anti-malarial drug target

No.

Compound

IC50(μM)

  

PfUDG

P. falciparum

HepG2 cytotoxicity

1

1-Methoxyethyl-6-(p-n-octylanilino)uracil

16.75

15.6

> 160

2

6-(Phenylhydrazino)uracil

77.5

12.8

27.5 ± 4.58

3

6-(p-n-Heptylanilino)uracil

> 400

5.0

ND

4

6-(4-Methylanilino)uracil

> 400

7.1

ND

5

6-(p-n-Propylanilino)uracil

> 400

7.9

ND

6

Uracil

> 400

10.0

ND

7

6-(p-n-Butylanilino)uracil

> 400

10.0

ND

8

3-(4-Hydroxybutyl)-6-(3-ethyl-4-methylanilino)uracil

> 400

10.2

ND

9

6-(p-n-Pentylanilino)uracil

> 400

10.5

ND

10

6-(p-i-Pentylanilino)uracil

> 400

11.0

ND

11

6-(p-i-Propylanilino)uracil

> 400

12.6

ND

12

6-(p-i-Butylanilino)uracil

> 400

16.5

ND

  1. ND = not-determined.